Zen Biotech Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
- Paid Up Capital ₹ 0.50 M
- Company Age 19 Year, 6 Months
- Last Filing with ROC 31 Mar 2023
- Revenue Growth %
- Profit Growth -10831.17%
- Ebitda -11592.56%
- Net Worth 9468.58%
- Total Assets 9900.00%
About Zen Biotech
Zen Biotech Private Limited (ZBPL) is a Private Limited Indian Non-Government Company incorporated in India on 21 July 2005 and has a history of 19 years and six months. Its registered office is in Roorkee, Uttarakhand.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.50 M, as per Ministry of Corporate Affairs (MCA) records.
Sanjay Singhal, Tarun Goel, Saurabh Goel, and Two other members serve as directors at the Company.
Company Details
- Location Roorkee, Uttarakhand
-
Telephone
+91-XXXXXXXXXX
- Email Address
-
Website
-
-
Social Media
-
Corporate Identity Details
-
CIN/LLPIN
U24232UR2005PTC030404
-
Company No.
030404
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
21 Jul 2005
-
Date of AGM
30 Sep 2023
-
Date of Balance Sheet
31 Mar 2023
-
Listing Status
Unlisted
-
ROC Code
Roc Uttarakhand
Industry
Who are the key members and board of directors at Zen Biotech?
Board Members (5)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sanjay Singhal
|
Director | 21-Jul-2005 | Current |
|
Tarun Goel
|
Director | 21-Jul-2005 | Current |
|
Saurabh Goel
|
Director | 21-Jul-2005 | Current |
|
Deepak Singhal
|
Director | 21-Jul-2005 | Current |
|
Sharad Singhal
|
Director | 21-Jul-2005 | Current |
Financial Performance of Zen Biotech.
Zen Biotech Private Limited, for the financial year ended 2023, experienced no change in revenue, with a 0% increase. The company also saw a substantial fall in profitability, with a 10831.17% decrease in profit. The company's net worth Soared by an impressive increase of 9468.58%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Zen Biotech?
Unlock access to Zen Biotech's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Zen Biotech?
Zen Biotech has a workforce of 3 employees as of Mar 23, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Zen Biotech, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Zen Biotech's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.